AgNovos Bioscience

*This message is intended for European health care provider audiences* AgNovos Bioscience is pleased to announce the achievement of our 400th OSSURE™ LOEP hip treated commercially. The Local Osteo-Enhancement Procedure is MDR approved and has been in clinical use in 5 countries across Europe. AgNovos would like to congratulate and thank our European surgeon community for your partnership in helping us achieve this significant milestone in our journey to help millions of women and men affected by bone disease. NOTE: AGN1 LOEP is not approved for commercial use in the U.S., Canada or anywhere outside of the European Economic Area, the U.K., or Switzerland.

*This message is intended for European health care provider audiences* AgNovos Bioscience is excited to announce the recent publication of LOEP data in JBMR Plus. Congratulations to the authors on this recognition. Please see the link for this open access manuscript outlining the results of QCT analysis of proximal femurs treated with AGN1 LOEP. https://lnkd.in/g3chrgzx NOTE: AGN1 LOEP is not approved for commercial use in the U.S., Canada or anywhere outside of the European Economic Area, the U.K., or Switzerland.

*This message is intended for European health care provider audiences* AgNovos Bioscience is excited to announce the recent publication of LOEP data in International Journal of Bone Fragility. Congratulations to the authors on this recognition. Please see the link for this open access manuscript outlining the results of patients treated with AGN1 on contralateral hip following hip fracture repair in the same surgical session in a single center pilot study. Link: https://lnkd.in/gkFF46_p NOTE: AGN1 LOEP is not approved for commercial use in the U.S., Canada or anywhere outside of the European Economic Area, the U.K., or Switzerland.

One more post to finish off Osteoporosis Awareness Month! Hip fractures are associated with chronic pain, reduced mobility, disability and increasing dependence, with 40% unable to walk independently, 60% requiring assistance a year later and less than half regaining their previous level of function. At AgNovos, we believe mobility is life and we stand with the millions impacted by osteoporosis and fragility fractures that can result from bone loss. Be proactive and learn more about what you can do to build stronger bones for a healthier future. #OsteoporosisAwareness, #BoneHealthMatters, #Fragilityfractures, #Osteoporosis, #Bonehealth

Osteoporosis Awareness Month Continues! If you’ve broken any bone (e.g., your wrist) after a minor fall from standing height, this could be a sign that you have osteoporosis. Be sure to speak to your doctor - because one broken bone is a warning of more to come! Osteoporosis doesn’t have to define your future. Knowledge is power! Commit to learning, testing, and strengthening your bones. Encourage friends & family to prioritize bone health, too! #OsteoporosisAwareness,#BoneHealthMatters,#Fragilityfractures,#Osteoporosis, #Bonehealth

May is Osteoporosis Awareness Month and time for another reminder to take care of your bones! Did you know that a simple fall, sneeze, or even a small bump can lead to a fracture if your bones are weakened by osteoporosis? Fragility fractures are more common than you think. Nearly 75% of hip, spine and distal forearm fractures occur among patients 65 years old or over. #OsteoporosisAwareness,#BoneHealthMatters,#Fragilityfractures,#Osteoporosis, #Bonehealth

May is Osteoporosis Awareness Month! This month, it’s time to shine a light on bone health and fracture prevention. Fragility fractures are more common than you think. One in three women and one in five men over the age of 50 will suffer a broken bone due to osteoporosis. #OsteoporosisAwareness, #BoneHealthMatters, #Fragilityfractures, #Osteoporosis, #Bonehealth

Pleased to be back at the World Congress on Osteoporosis! It’s been a busy few days here in Rome! Thanks to the organizers for another outstanding program.